BIOTECH (89) Cymabay Therapeutics: Seladelpar, an oral, selective peroxisome proliferator-activated receptor delta (PPARδ) agonist February 18, 2024February 19, 2024
BIOTECH (87) – Gilead’s Magrolimab (Hu5F9-G4) CD47-SIRPα blocker with Azacitidine for AML Phase 3 ENHANCE Study Terminated & Solid Tumor Partial Clinical Hold February 18, 2024
BIOTECH (86) – Kyverna Therapeutics: Autoimmune Disease CAR-T Therapy with Ingenui-T Manufacturing February 17, 2024February 17, 2024
BIOTECH (85) – Firefly Bio: Degrader-Antibody Conjugate (DAC) Platform Company Series A $94M February 17, 2024February 17, 2024
내가 쓰는 나의 삶 (30) – 미국인 10만명을 대상으로 한 55세에서 72세까지 18년간의 소득 변천 ICI의 연구보고서 February 17, 2024February 17, 2024